Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jirillo

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Haematologica|January 1, 1985
Hematologic toxicity of mitomycin-C (MMC) administered every three weeks in combination schedulesA Jirillo, R Demicheli
Tumori|May 1, 1996
Psoriasis and tamoxifen therapy: a case reportV D Ferrari, A Jirillo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2008
Bevacizumab in advanced cancer, too much or too little?A Jirillo, F Vascon, M Giacobbo
Tumori|June 30, 1980
Tamoxifen efficacy in advanced breast cancer previously treated with endocrine and cytotoxic therapyM De Lena, C Brambilla, A Jirillo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 6, 2009
Aloe-induced hypokalemia in a patient with breast cancer during chemotherapyZ Baretta, C Ghiotto, D Marino, et al.
Critical Reviews in Oncology/Hematology|March 15, 2006
Taking care of older cancer patients: results of a survey addressed to the Chiefs of the Medical Oncology Divisions in ItalySilvio Monfardini, L Pasetto, A Jirillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2007
Allocation of public sources in oncology: which role can ethics play?A Bernardi, A Jirillo, R Pegoraro, et al.
Tumori|August 31, 1980
Mitomycin C in metastatic breast cancer resistant to hormone therapy and conventional chemotherapyM De Lena, A Jirillo, C Brambilla, et al.
Tumori|December 23, 1998
Accidental overdose of melphalan per os in a 69-year-old woman treated for advanced endometrial carcinomaA Jirillo, G Gioga, G Bonciarelli, et al.
Immunopharmacology and Immunotoxicology|October 11, 2011
Sorafenib in hepatocellular carcinoma - a post marketing evaluationM P Trojniak, A C Palozzo, M Mazurek, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Haematologica|January 1, 1985
Hematologic toxicity of mitomycin-C (MMC) administered every three weeks in combination schedulesA Jirillo, R Demicheli
Tumori|May 1, 1996
Psoriasis and tamoxifen therapy: a case reportV D Ferrari, A Jirillo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2008
Bevacizumab in advanced cancer, too much or too little?A Jirillo, F Vascon, M Giacobbo
Tumori|June 30, 1980
Tamoxifen efficacy in advanced breast cancer previously treated with endocrine and cytotoxic therapyM De Lena, C Brambilla, A Jirillo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 6, 2009
Aloe-induced hypokalemia in a patient with breast cancer during chemotherapyZ Baretta, C Ghiotto, D Marino, et al.
Critical Reviews in Oncology/Hematology|March 15, 2006
Taking care of older cancer patients: results of a survey addressed to the Chiefs of the Medical Oncology Divisions in ItalySilvio Monfardini, L Pasetto, A Jirillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2007
Allocation of public sources in oncology: which role can ethics play?A Bernardi, A Jirillo, R Pegoraro, et al.
Tumori|August 31, 1980
Mitomycin C in metastatic breast cancer resistant to hormone therapy and conventional chemotherapyM De Lena, A Jirillo, C Brambilla, et al.
Tumori|December 23, 1998
Accidental overdose of melphalan per os in a 69-year-old woman treated for advanced endometrial carcinomaA Jirillo, G Gioga, G Bonciarelli, et al.
Immunopharmacology and Immunotoxicology|October 11, 2011
Sorafenib in hepatocellular carcinoma - a post marketing evaluationM P Trojniak, A C Palozzo, M Mazurek, et al.
Pageof 4